SCHEMBL4710426

SCHEMBL4710426

Cc1cccc(/C=C/c2cccc(N)c2)n1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 4/20 0.67
ALDH1A1 P00352 3/20 0.67
NPC1 O15118 2/20 0.67
KDM4E B2RXH2 2/20 0.67
HPGD P15428 2/20 0.67
NPSR1 Q6W5P4 2/20 0.67
GRM5 P41594 1/20 0.67
RAB9A P51151 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
HDAC6 Q9UBN7 1/20 0.67
MEN1 O00255 1/20 0.67
CYP3A4 P08684 1/20 0.67
CYP2D6 P10635 1/20 0.67
CYP2C9 P11712 1/20 0.67
PKM P14618 1/20 0.67
TSHR P16473 1/20 0.67
NFKB1 P19838 1/20 0.67
CYP2C19 P33261 1/20 0.67
THPO P40225 1/20 0.67
KMT2A Q03164 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4710427 1.00 GRM4 (0.67) GRM4ALDH1A1NPC1KDM4EHPGD
SCHEMBL4711083 0.83 ALDH1A1 (0.71) GRM4ALDH1A1NPC1KDM4EHPGD
SCHEMBL4711993 0.83 ALDH1A1 (0.71) GRM4ALDH1A1NPC1KDM4EHPGD
SCHEMBL4711084 0.83 ALDH1A1 (0.71) GRM4ALDH1A1NPC1KDM4EHPGD
SCHEMBL4711991 0.83 ALDH1A1 (0.71) GRM4ALDH1A1NPC1KDM4EHPGD
SCHEMBL4711823 0.81 ALDH1A1 (0.68) GRM4ALDH1A1NPC1KDM4EHPGD
SCHEMBL4711824 0.81 ALDH1A1 (0.68) GRM4ALDH1A1NPC1KDM4EHPGD
SCHEMBL29510104 0.80 GRM4 (1.00) GRM4ALDH1A1NPC1KDM4EHPGD
SCHEMBL179801 0.80 GRM4 (1.00) GRM4ALDH1A1NPC1KDM4EHPGD
SCHEMBL350949 0.80 GRM4 (1.00) GRM4ALDH1A1NPC1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP claimed
EP-0998459-A2 PYRIDINE DERIVATIVES Novartis AG (CH) 2000-05-10 EP claimed
WO-1999002497-A2 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 1999-01-21 WO claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed
US-6656957-B1 Marked and selective modulating, especially antagonistic, action at human metabotropic glutamate receptors (mGluRs); treatment of disorders such as epilepsy, cerebral ischemias, especially acute ischemias, spasticity etc. NOVARTIS AG (CH) 2003-12-02 US disclosed